IgG-antiphospholipid antibodies in follicular fluid of IVF-ET patients are related to low fertilization rate of their oocytes

American Journal of Reproductive Immunology

Volumn 55, Issue 5, 2006, Pages 341-348

  Matsubayashi, Hidehiko ^a   Sugi, Toshitaka ^a   Arai, Tadashi ^a   Shida, Masako ^a   Kondo, Akane ^a   Suzuki, Takahiro ^a   Izumi, Shun Ichiro ^a   McIntyre, John A ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b St Francis Hospital   (United States)

Author keywords

Cardiolipin; Embryo damage; IgG; Phosphatidylethanolamine; Phosphatidylserine; Trophoblast

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; EMBRYOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; INCIDENCE; OOCYTE; OVARY FOLLICLE FLUID; PRIORITY JOURNAL; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR FLUID; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFERTILITY, FEMALE; MIDDLE AGED; OOCYTES; RISK FACTORS; TREATMENT FAILURE;

EID: 33645468615     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2006.00374.x     Document Type: Article

References (48)

1. American Society for Reproductive Medicine Practice Committee Report: Antiphospholipid Antibodies Do Not Affect IVF Success. American Society for Reproductive Medicine, Birmingham, Alabama, 1999, 1 -3.
2. The Practice Committee of the American Society for Reproductive Medicine: Antiphospholipid antibodies do not affect IVF success. Fertil Steril 2004; 82 (Suppl. 1): S184 -S185.
3. American Society for Reproductive Immunology Antiphospholipid Antibody Committee: A rational basis for antiphsopholipid antibody testing and selective immunotherapy in assisted reproduction: A rebuttal to the American Society for Reproductive Medicine Practice Committee Opinion. Fertil Steril 2000; 74: 631-634.
4. Gleicher N, Vidali A, Karande V: The immunological 'Wars of the Roses': disagreements amongst reproductive immunologists. Hum Reprod 2002; 17: 539-542.
5. Kaider BD, Coulam CB, Roussev RG: Murine embryos as a direct target for some human autoantibodies in vitro. Hum Reprod 1999; 14: 2556-2561.
6. Sthoeger ZM, Mozes E, Tartakovsky B: Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci U S A 1993; 90: 6464-6467.
7. Tartakovsky B, Bermas BL, Sthoeger Z, Shearer GM, Mozes E: Defective maternal-fetal interaction in a murine autoimmune model. Hum Reprod 1996; 11: 2408-2411.
8. Azem F, Geva E, Amit A, Lerner-Geva L, Scwartz T, Ben-Yosef D, Yovel I, Lessing JB: High levels of anticardiolipin antibodies in patients with abnormal embryo morphology who attended an in vitro fertilization program. Am J Reprod Immunol 1998; 39: 161-163.
9. Chamley LW, Duncalf AM, Nitchell MD, Johnson PM: Action of anticardiolipin and antibodies to β2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 1998; 352: 1037-1038.
10. Rote NS, Vogt E, de Vere G, Obringer AR, Ng A-K: The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome. Am J Reprod Immunol 1998; 39: 125-136.
11. McIntyre JA. Antiphospholipid antibodies (aPL) in implantation failures. Am J Reprod Immunol 2003; 49: 221-229.
12. Matsubayashi H, Sugi T, Arai T, Kondo A, Suzuki T, Izumi S-I, McIntyre JA, Makino T. Different antiphospholipid antibody specificities are found in association with early repeated pregnancy loss versus recurrent IVF-failure patients. Am J Reprod Immunol 2001; 46: 323-329.
13. Suzuki T, Izumi S, Matsubayashi H, Awaji H, Yoshikata K, Makino T. Impact of ovarian endometrioma on oocytes and pregnancy outcome in in vitro fertilization. Fertil Steril 2005; 83: 908-913.
14. Ledee-Bataille N, Lapree-Delage G, Taupin JL, Dubanchet S, Taieb J, Moreau JF, Chaouat G: Follicular fluid concentration of leukaemia inhibitory factor is decreased among women with polycystic ovarian syndrome during assisted reproductive cycles. Hum Reprod 2001; 16: 2073-2078.
15. Amato G, Conte M, Mazziotti G, Lalli E, Vitolo G, Tucker AT, Bellastella A, Carella C, Izzo A: Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol 2003; 101: 1177-1182.
16. Veeck LL. Atlas of the Human Oocyte and Early Conceptus. Baltimore, MD, Williams& Wilkins, 1991; 121-149.
17. Sugi T, Katsunuma J, Izumi S, McIntyre JA, Makino T: Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses. Fertil Steril 1999; 71: 1060-1065.
18. El-Roeiy A, Gleicher N, Friberg J, Confino E, Dudkiewicz A: Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization. Obstet Gynecol 1987; 70: 163-170.
19. Fisch B, Tadir Y, Rikover Y, Ovadia J, Shohat L, Witz IP, Zurgil N, Yron I: The relationship between in vitro fertilization and naturally occurring antibodies: Evidence for increased production of antiphosphlipid autoantibodies. Fertil Steril 1991; 56: 718-724.
20. Geva E, Vardinon N, Yaron Y, Burke M, Lessing JB, Amit A, Yovel I: Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization. Fertil Steril 1994; 62: 802-806.
21. Birkenfeld A, Mukaida T, Minichiello L, Jackson M, Kase NG, Yemini M: Incidence of autoimmune antibodies in failed embryo transfer cycles. Am J Reprod Immunol 1994; 31: 65-68.
22. Kaider BD, Price DE, Roussev RG, Coulam CB: Antiphospholipid antibody prevalence in patients with IVF-failure. Am J Reprod Immunol 1996; 35: 388-393.
23. Coulam CB, Kaider BD, Kaider AS, Janowicz P, Roussev RG: Antiphospholipid antibodies associated with implantation failure after IVF/ET. J Assist Reprod Genet 1997; 14: 603-608.
24. Balasch J, Creus M, Fabregues F, Reverter JC, Carmona F, Tassies D, Font J, Vanrell JA: Antiphospholipid antibodies and human reproductive failure. Hum Reprod 1996; 11: 2310-2315.
25. Chilcott IT, Margara R, Cohen H, Rai R, Skull J, Pickering W, Regan L: Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. Fertil Steril 2000; 73: 526-530.
26. Kutteh WH, Yetman DL, Chantilis SJ, Crain J: Effect of antiphospholipid antibodies in women undergoing in vitro fertilization: Role of heparin and aspirin. Hum Reprod 1997; 12: 1171-1175.
27. Geva E, Amit A, Lerner-Geva L, Azem F, Yovel I, Lessing JB: Autoimmune disorders: Another possible cause for in vitro fertilization and embryo transfer failure. Hum Reprod 1995; 10: 2560-2563.
28. Hornstein MD, Davis OK, Massey JB, Paulson RJ, Collins JA: Antiphospholipid antibodies and in vitro fertilization success: A meta-analysis. Fertil Steril 2000; 73: 330-333.
29. Birdsall MA, Lockwood GM, Ledger WL, Johnson PM, Chamley LW: Antiphospholipid antibodies in women having in vitro fertilization. Hum Reprod 1996; 11: 1185-1189.
30. Denis AL, Bergh PA, Guido M, Brenner C, Adler RD, Scott RT: Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients. Fertil Steril 1997; 67: 1084-1090.
31. Gleicher N, Liu H-C, Dudkiewicz A, Rosenwaks Z, Kaberlein G, Pratt D, Karande V: Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success. Am J Obstet Gynecol 1994; 170: 1145-1149.
32. Kowalik A, Branch W, Vichnin M, Berkekey AS, Liu H-C: Midfollicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with in vitro fertilization outcome. Fertil Steril 1997; 68: 298-304.
33. Sher G, Feinman M, Zouves C, Kuttner G, Maassarani G, Salem R, Matzner W, Ching W, Chong P: High fecundity rates following in vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod 1994; 9: 2278-2283.
34. Sher G, Zouves C, Feinman M, Maassarani G, Matzner W, Chong P, Ching W: A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF-failure associated with antiphospholipid antibodies. Am J Reprod Immunol 1998; 39: 391-394.
35. Geva E, Amit A, Lerner-Geva L, Yaron Y, Daniel Y, Schwartz T, Azem F, Yovel I, Lessing JB: Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: A prospective study. Am J Reprod Immunol 2000; 43: 36-40.
36. Geva E, Amit A, Lerner-Geva L, Lessing JB: Prevention of early pregnancy loss in autoantibody seropositive women. Lancet 1998; 351: 34-35.
37. Schenk LM, Butler L, Monis JP, Cox B, Leete J, Abuhamed A, Oehninger S, Muasher: Heparin and aspirin treatment yields higher implantation rates in IVF patients with antiphospholipid antibody seropositive compared to untreated seronegative patients. Fertil Steril 1996; Suppl. 11: S39. (Abstract O-076).
38. Hatasaka H: Immunologic factors in infertility. Clin Obstet Gynecol 2000; 43: 830-843.
39. Coulam CB: Antiphospholipid antibody round table report. Am J Reprod Immunol 2002; 48: 262-265.
40. Coulam CB: The role of antiphospholipid antibodies in reproduction: questions answered and raised at the 18th Annual Meeting of the American Society of Reproductive Immunology. Am J Reprod Immunol 1999; 41: 1-4.
41. Lyden TW, Vogt E, Ng A-K, Johnson PM, Rote NS: Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. J Reprod Immunol 1992; 22: 1-14.
42. Katsuragawa H, Rote NS, Inoue T, Narukawa S, Kanzaki H, Mori T: Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts. Am J Obstet Gynecol 1995; 172: 1592-1597.
43. Adler RR, Ng A-K, Rote NS: Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol Reprod 1995; 53: 905-910.
44. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mori T, Rote NS: Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997; 56: 50-58.
45. Chavez DJ, McIntyre JA: Sera from women with histories of repeated pregnancy losses cause abnormalities in mouse peri-implantation blastocysts. J Reprod Immunol 1984; 6: 273-281.
46. Gris, J-C, Quere I, SanMarco M, Boutiere B, Mercier E, Amril J, Hubert A-M, Ripart-Neveu S, Hoffett M, Tailland M-L, Rousseau O, Monypeyroux F, Dauzat M, Sampol J, Daures J-P, Berlan J, Mares P: Antiphodpholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. Thromb Haemost 2000; 84: 228-236.
47. Stern C, Chamley L, Norris H, Hale L, Baker HWG: A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril 2003; 80: 376-383.
48. Sher G, Matzner W, Feinman M, Maassarani G, Zouves C, Chong P, Wendell C: The selective use of heparin-aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am J Reprod Immunol 1998; 40: 74-82.